SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Natus Medical Inc – ‘8-K’ for 1/30/04

On:  Friday, 1/30/04, at 4:12pm ET   ·   For:  1/30/04   ·   Accession #:  1193125-4-12054   ·   File #:  0-33001

Previous ‘8-K’:  ‘8-K’ on / for 11/12/03   ·   Next:  ‘8-K’ on / for 2/26/04   ·   Latest:  ‘8-K’ on / for 7/21/22

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 1/30/04  Natus Medical Inc                 8-K:5,7     1/30/04    2:22K                                    RR Donnelley/FA

Current Report   —   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     15K 
 2: EX-99.1     Press Release Dated January 30, 2004                HTML     11K 


8-K   —   Current Report


This is an HTML Document rendered as filed.  [ Alternative Formats ]



  FORM 8-K  

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 8-K

 


 

Current Report

 

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported) January 30, 2004

 


 

Natus Medical Incorporated

(Exact name of registrant as specified in its charter)

 


 

Delaware   000-33001   77-0154833

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

1501 Industrial Road, San Carlos, California 94070
(Address of principal executive offices)                     (Zip Code)

 

Registrant’s telephone number, including area code: (650) 802-0400

 

Not applicable

(Former name or former address, if changed since last report)

 



ITEM 5. OTHER EVENTS AND REQUIRED REGULATION FD DISCLOSURE.

 

On January 30, 2004, Natus Medical Incorporated (the “Company”) is issuing a press release regarding the resignation of Tim C. Johnson, its president, chief executive officer and chief operating officer and a member of its Board of Directors. Mr. Johnson has agreed to continue to serve in his current capacity until a successor has been named. A copy of the press release is furnished as Exhibit 99.1 to this Form 8-K.

 

The information in this Form 8-K and the exhibit attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, regardless of any general incorporation language in such filing.

 

ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.

 

(c) Exhibits.

 

Exhibit No.

  

Description


99.1    Press release dated January 30, 2004 announcing the resignation of Tim C. Johnson.

 

-2-


SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

   

NATUS MEDICAL INCORPORATED

Dated: January 30, 2004

 

By:

 

/S/    MARK E. FOSTER        


       

Mark E. Foster

       

Vice President and General Counsel

 

-3-


Index to Exhibits

 

Exhibit No.

  

Description


99.1    Press release dated January 30, 2004 announcing the resignation of Tim C. Johnson.

 

-4-


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-K’ Filing    Date    Other Filings
Filed on / For Period End:1/30/04None on these Dates
 List all Filings 
Top
Filing Submission 0001193125-04-012054   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Wed., Apr. 24, 11:27:53.2am ET